Recap of Stuart Kurtz NAME & SOFT 2025 Presentations

In October 2025, toxicologist Stuart Kurtz made presentations at both the National Association of Medical Examiners 2025 Conference in Louisville, Kentucky, and at the Society of Forensic Toxicologists 2025 Conference in Portland, Oregon. NAME 2025 Recap: Nitazenes ...

A Case of Drug Reemergence: The Synthetic Cannabinoid, 5F-ADB 

By Kevin Shanks, D-ABFT-FT It has been a little over 4 years since Axis mentioned synthetic cannabinoids on this blog. So, briefly, synthetic cannabinoids are man-made compounds that bind to cannabinoid receptors 1 (CB1) and 2 (CB2) in the body and mediate effects of...

Recap of Kevin Shanks NAME & SOFT 2025 Presentations

In October 2025, toxicologist Kevin Shanks made presentations at both the National Association of Medical Examiners 2025 Conference in Louisville, Kentucky, and at the Society of Forensic Toxicologists 2025 Conference in Portland, Oregon. NAME 2025 Recap:...

Drug Primer: 7-OH Mitragynine

By Stuart Kurtz, D-ABFT-FT Axis Forensic Toxicology has previously written on kratom and cases involving kratom fatalities. As a quick recap, Mitragyna speciosa, is a tree or shrub that grows in southeast Asia. It’s part of the Rubiaceae family which includes coffee...

The Utility of Drug Testing in Urine

By Laureen Marinetti, PhD, F-ABFT As part of its whole case approach, Axis Forensic Toxicology includes urine drug testing alongside blood testing in both the Comprehensive Panel with Analyte Assurance™ and Drugs of Abuse Panel. The standard urine screen typically...

A New Fentanyl Derivative: ortho-Methylfentanyl

By Kevin Shanks, M.S., D-ABFT-FT As we have discussed on this blog several times in the past, novel psychoactive substances (NPS) come in different varieties, which include cannabinoids, stimulants, opioids, benzodiazepines, and hallucinogens. One of Axis Forensic...